Historical record - last NADAC publication: 11/20/2019
Product Information
METFORMIN HCL 850 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0282 per EA under NDC 67877021810. Its NADAC has been published 314 times since Nov 28, 2013.
Strength
850 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877021810
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
11/20/2019
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091184On Market Since
1/31/2011
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 850 MG TABLET has been published 314 times since Nov 28, 2013, and over the history we have for it it has declined 26.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0282 per EA |
|---|---|
| All-time high | $0.0436 (Feb 12, 2014) |
| All-time low | $0.0270 (Apr 17, 2019) |
| Median price | $0.0323 |
| Average price | $0.0334 |
| Largest weekly change | -15.4% (Aug 19, 2015) |
| Weeks tracked | 314 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 13 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METFORMIN HCL 850 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 850 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.0282 per EA (NDC 67877021810), effective Nov 27, 2019.
How has the price of METFORMIN HCL 850 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 850 MG TABLET has declined 26.5%. It has been tracked across 314 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 850 MG TABLET?
Since Nov 28, 2013, the NADAC for METFORMIN HCL 850 MG TABLET has ranged from a low of $0.0270 (Apr 17, 2019) to a high of $0.0436 (Feb 12, 2014), with a median of $0.0323 per EA.
Are there cheaper alternatives to METFORMIN HCL 850 MG TABLET?
Yes. 13 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METFORMIN HCL 850 MG TABLET, is $0.0247 per EA — about 12% below METFORMIN HCL 850 MG TABLET.
Who manufactures METFORMIN HCL 850 MG TABLET?
METFORMIN HCL 850 MG TABLET (NDC 67877021810) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification